Non-Melanoma Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Radiation Therapy and Malignant T-Cell Levels in Early-Stage Mycosis Fungoides

By: Sarah Campen, PharmD
Posted: Tuesday, January 21, 2020

Low-dose radiation therapy appears to eradicate malignant T cells in some patients with mycosis fungoides, according to research by John T. O’Malley, MD, PhD, of Dana-Farber Cancer Institute and Brigham and Women’s Cancer Center, Boston, and colleagues. The study, published in Clinical Cancer Research, also found that radiation therapy improved survival in patients with high-risk early-stage disease.

A total of 20 lesional skin sites from 18 patients with mycosis fungoides were biopsied before and after treatment with either low-dose (8 Gy) radiation therapy (n = 16) or topical steroids (n = 4). High-throughput T-cell receptor sequencing of the TCRB gene measured levels of the malignant T cells in the lesion samples.

Low-dose radiation therapy eradicated malignant T cells in 5 of 16 lesions and reduced levels by more than 90% in the remaining 11 lesions. Patients treated with topical steroids appeared to have clinical improvement, but levels of the malignant T-cell clone were not reduced. The researchers discovered that the number of residual malignant T cells was a predictor of lesion recurrence.

Dr. O’Malley and colleagues also completed a retrospective chart review of 47 patients with high-risk, early-stage mycosis fungoides. They found that patients who received radiation as part of their treatment regimen had prolonged overall survival compared with patients who did not receive radiation.

Disclosure: For full disclosures of the study authors, visit clincancerres.aacrjournals.org.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.